FindTrial
Sign In

Treatment of common warts

Evaluation of efficacy and safety of intralesional bleomycin in the treatment of common warts: a pilot study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/07/009028
Enrollment
50
Registered
2017-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Common warts

Interventions

Intervention1: Bleomycin: Each wart and the adjacent skin will be cleansed with spirit and bleomycin (1 mg/ml) injected intralesionally until blanching of the lesion. The amount of bleomycin into a si

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 50 consecutive patients with common warts

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Complete disappearance of warts,recurrence, or any adverse effects.Satisfaction level (Likert scale) at end of study. Satisfaction level (Likert scale) at end of studyTimepoint: Every month after completion of treatment.—

Secondary

MeasureTime frame
Satisfaction level (Likert scale) at end of studyTimepoint: At end of study or at disappearance of warts, which ever is early—

Countries

India

Contacts

Public ContactDr Vikram Mahajan

Dr R P Govt Medical College

vkm1@rediffmail.com9418007941

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026